(1->4)-beta-D-glucan multiple interactions ISO RGD:1312233 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLA2G12A mRNA CTD PMID:36331819 (RS)-coclaurine multiple interactions ISO RGD:1312233 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA CTD PMID:28843594 (RS)-norcoclaurine multiple interactions ISO RGD:1312233 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA CTD PMID:28843594 (S)-coclaurine multiple interactions ISO RGD:1312233 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA CTD PMID:28843594 (S)-nicotine decreases expression ISO RGD:1312233 6480464 Nicotine results in decreased expression of PLA2G12A mRNA CTD PMID:17997037 1,2-dimethylhydrazine increases expression ISO RGD:1312233 6480464 1, 2-Dimethylhydrazine results in increased expression of PLA2G12A mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of PLA2G12A mRNA CTD PMID:25380136 17beta-estradiol increases expression ISO RGD:1312232 6480464 Estradiol results in increased expression of PLA2G12A mRNA CTD PMID:19167446 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of PLA2G12A mRNA CTD PMID:32145629 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1312233 6480464 2 more ... CTD PMID:21851831 , PMID:32352317 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO RGD:1312233 6480464 2 more ... CTD PMID:20005886 , PMID:21851831 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1312233 6480464 2 more ... CTD PMID:16214954 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1312233 6480464 Tetrachlorodibenzodioxin results in increased expression of PLA2G12A mRNA CTD PMID:18796159 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1312233 6480464 Tetrachlorodibenzodioxin affects the expression of PLA2G12A mRNA CTD PMID:20702594 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PLA2G12A mRNA CTD PMID:21215274 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PLA2G12A mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G12A mRNA] CTD PMID:21215274 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1312233 6480464 Trinitrobenzenesulfonic Acid results in increased expression of PLA2G12A mRNA CTD PMID:17982090 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of PLA2G12A mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl affects expression ISO RGD:1312233 6480464 3 more ... CTD PMID:20702594 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of PLA2G12A mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1312233 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of PLA2G12A mRNA CTD PMID:18648102 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of PLA2G12A mRNA CTD PMID:30047161 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PLA2G12A mRNA CTD PMID:23385219 more ... all-trans-retinoic acid increases expression ISO RGD:1312232 6480464 Tretinoin results in increased expression of PLA2G12A mRNA CTD PMID:21934132 antirheumatic drug increases expression ISO RGD:1312232 6480464 Antirheumatic Agents results in increased expression of PLA2G12A mRNA CTD PMID:24449571 Aroclor 1254 increases expression ISO RGD:1312233 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of PLA2G12A mRNA CTD PMID:25270620 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of PLA2G12A gene CTD PMID:35440735 benzo[a]pyrene increases expression ISO RGD:1312233 6480464 Benzo(a)pyrene results in increased expression of PLA2G12A mRNA CTD PMID:19770486 beta-hexachlorocyclohexane increases expression ISO RGD:1312233 6480464 beta-hexachlorocyclohexane results in increased expression of PLA2G12A mRNA CTD PMID:25270620 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PLA2G12A mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1312232 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLA2G12A gene CTD PMID:31601247 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PLA2G12A mRNA CTD PMID:32145629 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PLA2G12A gene CTD PMID:28505145 buspirone increases expression EXP 6480464 Buspirone results in increased expression of PLA2G12A mRNA CTD PMID:24136188 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of PLA2G12A mRNA CTD PMID:25993096 caffeine multiple interactions ISO RGD:1312233 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA CTD PMID:28843594 cannabidiol increases expression ISO RGD:1312233 6480464 Cannabidiol results in increased expression of PLA2G12A mRNA CTD PMID:31052254 carbamazepine affects expression ISO RGD:1312232 6480464 Carbamazepine affects the expression of PLA2G12A mRNA CTD PMID:24752500 carbon nanotube increases expression ISO RGD:1312233 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube affects expression ISO RGD:1312233 6480464 Nanotubes, Carbon affects the expression of PLA2G12A mRNA CTD PMID:31978390 chlordecone increases expression ISO RGD:1312233 6480464 Chlordecone results in increased expression of PLA2G12A mRNA CTD PMID:33711761 chlorpyrifos increases expression ISO RGD:1312233 6480464 Chlorpyrifos results in increased expression of PLA2G12A mRNA CTD PMID:37019170 chromium(6+) affects expression ISO RGD:1312233 6480464 chromium hexavalent ion affects the expression of PLA2G12A mRNA CTD PMID:28472532 cobalt dichloride decreases expression ISO RGD:1312232 6480464 cobaltous chloride results in decreased expression of PLA2G12A mRNA CTD PMID:19376846 copper(II) sulfate decreases expression ISO RGD:1312232 6480464 Copper Sulfate results in decreased expression of PLA2G12A mRNA CTD PMID:19549813 coumarin increases expression EXP 6480464 coumarin results in increased expression of PLA2G12A mRNA CTD PMID:18480146 cyclosporin A increases expression ISO RGD:1312232 6480464 Cyclosporine results in increased expression of PLA2G12A mRNA CTD PMID:20106945 cyproconazole increases expression ISO RGD:1312233 6480464 cyproconazole results in increased expression of PLA2G12A mRNA CTD PMID:22334560 dextran sulfate multiple interactions ISO RGD:1312233 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLA2G12A mRNA CTD PMID:29950665 dibutyl phthalate decreases expression ISO RGD:1312233 6480464 Dibutyl Phthalate results in decreased expression of PLA2G12A mRNA CTD PMID:17361019 , PMID:21266533 diclofenac affects expression ISO RGD:1312232 6480464 Diclofenac affects the expression of PLA2G12A mRNA CTD PMID:24752500 difenoconazole increases expression ISO RGD:1312233 6480464 difenoconazole results in increased expression of PLA2G12A mRNA CTD PMID:34425431 dioxygen multiple interactions ISO RGD:1312233 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLA2G12A mRNA CTD PMID:30529165 diquat increases expression ISO RGD:1312233 6480464 Diquat results in increased expression of PLA2G12A mRNA CTD PMID:36851058 dorsomorphin multiple interactions ISO RGD:1312232 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 elemental selenium multiple interactions ISO RGD:1312232 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of PLA2G12A mRNA CTD PMID:19244175 elemental selenium decreases expression ISO RGD:1312232 6480464 Selenium results in decreased expression of PLA2G12A mRNA CTD PMID:19244175 entinostat increases expression ISO RGD:1312232 6480464 entinostat results in increased expression of PLA2G12A mRNA CTD PMID:26272509 , PMID:27188386 entinostat multiple interactions ISO RGD:1312232 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G12A mRNA CTD PMID:27188386 epoxiconazole increases expression ISO RGD:1312233 6480464 epoxiconazole results in increased expression of PLA2G12A mRNA CTD PMID:22334560 ethanol increases expression ISO RGD:1312233 6480464 Ethanol results in increased expression of PLA2G12A mRNA CTD PMID:19167417 flutamide increases expression EXP 6480464 Flutamide results in increased expression of PLA2G12A mRNA CTD PMID:24136188 folic acid decreases expression ISO RGD:1312233 6480464 Folic Acid results in decreased expression of PLA2G12A mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO RGD:1312232 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLA2G12A gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of PLA2G12A mRNA CTD PMID:26194646 Heptachlor epoxide increases expression ISO RGD:1312233 6480464 Heptachlor Epoxide results in increased expression of PLA2G12A mRNA CTD PMID:25270620 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PLA2G12A mRNA CTD PMID:22129741 inulin multiple interactions ISO RGD:1312233 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PLA2G12A mRNA CTD PMID:36331819 lead(0) affects expression ISO RGD:1312232 6480464 Lead affects the expression of PLA2G12A mRNA CTD PMID:28903495 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of PLA2G12A mRNA CTD PMID:24136188 levofloxacin increases expression EXP 6480464 Levofloxacin results in increased expression of PLA2G12A mRNA CTD PMID:24136188 metformin affects expression EXP 6480464 Metformin affects the expression of PLA2G12A mRNA CTD PMID:31324951 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of PLA2G12A mRNA CTD PMID:28935588 methotrexate increases expression ISO RGD:1312232 6480464 Methotrexate results in increased expression of PLA2G12A mRNA CTD PMID:24449571 methylmercury chloride decreases expression ISO RGD:1312232 6480464 methylmercuric chloride results in decreased expression of PLA2G12A mRNA CTD PMID:23179753 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PLA2G12A mRNA CTD PMID:22129741 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of PLA2G12A mRNA CTD PMID:25380136 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of PLA2G12A mRNA CTD PMID:24136188 nicotine decreases expression ISO RGD:1312233 6480464 Nicotine results in decreased expression of PLA2G12A mRNA CTD PMID:17997037 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of PLA2G12A mRNA CTD PMID:24136188 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of PLA2G12A mRNA CTD PMID:33484710 ozone multiple interactions ISO RGD:1312233 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PLA2G12A mRNA CTD PMID:34911549 ozone increases expression EXP 6480464 Ozone results in increased expression of PLA2G12A mRNA CTD PMID:35737395 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PLA2G12A mRNA CTD PMID:17202762 paracetamol increases expression ISO RGD:1312232 6480464 Acetaminophen results in increased expression of PLA2G12A mRNA CTD PMID:21420995 paracetamol affects expression ISO RGD:1312233 6480464 Acetaminophen affects the expression of PLA2G12A mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1312233 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLA2G12A mRNA more ... CTD PMID:36331819 phenformin increases expression EXP 6480464 Phenformin results in increased expression of PLA2G12A mRNA CTD PMID:31324951 phenobarbital multiple interactions ISO RGD:1312233 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PLA2G12A mRNA] CTD PMID:19482888 phenobarbital increases expression ISO RGD:1312233 6480464 Phenobarbital results in increased expression of PLA2G12A mRNA CTD PMID:19270015 more ... piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of PLA2G12A mRNA CTD PMID:22484513 pirinixic acid increases expression ISO RGD:1312233 6480464 pirinixic acid results in increased expression of PLA2G12A mRNA CTD PMID:18445702 , PMID:23811191 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1312233 6480464 Pregnenolone Carbonitrile results in increased expression of PLA2G12A mRNA CTD PMID:28903501 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of PLA2G12A mRNA CTD PMID:30047161 propiconazole increases expression ISO RGD:1312233 6480464 propiconazole results in increased expression of PLA2G12A mRNA CTD PMID:22334560 rotenone increases expression EXP 6480464 Rotenone results in increased expression of PLA2G12A mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1312232 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom multiple interactions ISO RGD:1312232 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of PLA2G12A mRNA CTD PMID:19244175 selenium atom decreases expression ISO RGD:1312232 6480464 Selenium results in decreased expression of PLA2G12A mRNA CTD PMID:19244175 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of PLA2G12A mRNA CTD PMID:25993096 sunitinib increases expression ISO RGD:1312232 6480464 Sunitinib results in increased expression of PLA2G12A mRNA CTD PMID:31533062 tacrolimus hydrate increases expression ISO RGD:1312233 6480464 Tacrolimus results in increased expression of PLA2G12A mRNA CTD PMID:25270620 tetrachloromethane increases expression ISO RGD:1312233 6480464 Carbon Tetrachloride results in increased expression of PLA2G12A mRNA CTD PMID:27339419 , PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PLA2G12A mRNA CTD PMID:23411599 titanium dioxide multiple interactions ISO RGD:1312233 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLA2G12A mRNA CTD PMID:29950665 trichloroethene increases expression ISO RGD:1312233 6480464 Trichloroethylene results in increased expression of PLA2G12A mRNA CTD PMID:19448997 trichostatin A increases expression ISO RGD:1312232 6480464 trichostatin A results in increased expression of PLA2G12A mRNA CTD PMID:24935251 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of PLA2G12A mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:1312232 6480464 Valproic Acid affects the expression of PLA2G12A mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1312232 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G12A mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1312232 6480464 Valproic Acid results in increased expression of PLA2G12A mRNA CTD PMID:23179753 more ... vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of PLA2G12A gene CTD PMID:31079544 vitamin E multiple interactions ISO RGD:1312232 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of PLA2G12A mRNA CTD PMID:19244175 vitamin E decreases expression ISO RGD:1312232 6480464 Vitamin E results in decreased expression of PLA2G12A mRNA CTD PMID:19244175 yohimbine multiple interactions ISO RGD:1312233 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA CTD PMID:28843594